Thilo Hackert - Concepedia

Author

Thilo Hackert

Also Known As

Andrew A Gumbs, Carla Davina Grundmann, Christos Dervenis, Cosimo Sperti, Daryl Gray, Hackert Thilo, Hackert, T., Hackert, Thilo, Hackert, Thilo 1971-, M Gaziano, J Michael

1.2K

Publications

33.7K

Citations

H-Index

185

Concepts

All Affiliations

Heidelberg University University Hospital Heidelberg German Cancer Research Center Universität Hamburg University Medical Center Hamburg-Eppendorf

About

Thilo Hackert is an author at Heidelberg University specializing in medicine, surgery, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	49	124	7.6K
2	Health Sciences	8	8	550
3	Engineering	4	4	141
4	Natural Sciences	2	2	51
5	Education	1	1	35

Thilo Hackert

344

Publications

22.1K

Citations

H-Index

Page 1

	Year	Citations
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial John P. Neoptolemos, Daniel H. Palmer, Paula Ghaneh, The Lancet	2017	1.9K
International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017 Shuji Isaji, Shugo Mizuno, John A. Windsor, Pancreatology	2017	751
Locally Advanced Pancreatic Cancer Thilo Hackert, Milena Sachsenmaier, Ulf Hinz, Annals of Surgery	2016	511
Pancreatic Cancer Surgery in the New Millennium Werner Hartwig, Thilo Hackert, Ulf Hinz, Annals of Surgery	2011	415
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Thierry Conroy, Per Pfeiffer, Valérie Vilgrain, Annals of Oncology Surgical OncologyPancreatic CancerGastrointestinal OncologyMedicineGastroenterology	2023	413
Toward the blood-borne miRNome of human diseases Andreas Keller, Petra Leidinger, Andrea S. Bauer, Nature Methods Disease MechanismMedicinePathogenesisPathologyBlood-borne Mirnome	2011	360
Pancreatic Cancer Surgery Oliver Strobel, Thomas Hank, Ulf Hinz, Annals of Surgery	2016	325
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial Paula Ghaneh, Daniel H. Palmer, Silvia Cicconi, The Lancet. Gastroenterology & hepatology Surgical OncologyImmediate SurgeryPancreatic CancerGastrointestinal OncologyMedicine	2022	294
CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy Werner Hartwig, Oliver Strobel, Ulf Hinz, Annals of Surgical Oncology Surgical OncologyPancreatic CancerGastrointestinal OncologyMedicinePancreatic Surgery	2012	290
Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA) Jony van Hilst, Thijs de Rooij, Sjors Klompmaker, Annals of Surgery	2017	271

Page 1